Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Age-Related Blood Pressue Patterns in Lupus

Renée Bacher  |  June 15, 2020

Rheumatologists should not be falsely reassured by a normal mean blood pressure in lupus patients, according to a study from Johns Hopkins University that found age-related blood pressure patterns in systemic lupus erythematosus (SLE) differ from the general population and that increased diastolic blood pressure variability (BPV) is highly associated with cardiovascular events in SLE.1…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:atherosclerosisblood pressure variability (BPV)cardiovascular event

nukeaf / shutterstock.com

The History of Treating Lupus with Hydroxychloroquine

Ruth Jessen Hickman, MD  |  June 15, 2020

Given how unexpectedly front and center hydroxychloroquine has been in discussions about the treatment of COVID-19 this year, it makes sense to look at how it became so central to the treatment of a rheumatologic condition. In 1991, an article appeared in The New England Journal of Medicine that would alter the way rheumatologists approached…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Lost & Foundretinopathy

Advocacy in a COVID-19 America

Ellen M. Gravallese, MD  |  June 15, 2020

These are truly extraordinary times. The COVID-19 pandemic has affected the rheumatology community, both providers and patients, in many ways, and our advocacy efforts are now more important than ever to ensure policymakers hear us and help address the issues facing our community. As with so many things during this pandemic, we are reimagining advocacy…

Filed under:Legislation & AdvocacyPresident's PerspectiveTechnology Tagged with:COVID-19RheumPAC

We Make a Difference

Philip Seo, MD, MHS  |  June 15, 2020

“No!” she screamed. My niece just finished her first semester as a freshman at the University of St. Andrews in Scotland. If the institution sounds familiar to you, it may be because you remember a particularly famous graduate—William Windsor, who sometimes goes by his formal titles: Duke of Cambridge and heir to the British throne….

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19

Collaborate, Innovate & Learn at ACR Convergence 2020: The ACR’s All-Virtual Annual Meeting

From the College  |  June 11, 2020

ACR Convergence 2020—the ACR’s annual meeting—will be presented online. Get ready for an innovative experience.

Filed under:Professional Topics Tagged with:ACR Convergence 2020online education

Ethics Forum: Medical Ethical Considerations for COVID-19

David Y. Chen, MD, PhD, & Eric J. Gapud, MD, PhD, on behalf of the ACR Committee for Ethics & Conflicts of Interest  |  June 8, 2020

Prescribing stewardship is just one ethical consideration facing rheumatologists during the COVID-19 pandemic.

Filed under:Ethics Tagged with:COVID-19Ethics Forum

Advocacy During a Pandemic: An Update from the Government Affairs Committee

Blair Solow, MD  |  June 5, 2020

Although the COVID-19 outbreak has shifted the focus and approach of advocacy efforts, ACR staff and the Government Affairs Committee continue to work on behalf of rheumatology providers and patients.

Filed under:Legislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)Virtual Hill Day

In the Lungs: Asthma & COPD May Be Early, Independent Risk Factors for RA

Carina Stanton  |  June 1, 2020

Recent research found women with COPD and asthma—even those who have never smoked—are at a higher risk of developing rheumatoid arthritis…

Filed under:ConditionsRheumatoid Arthritis Tagged with:2019 ACR/ARP Annual Meetingasthmachronic obstructive pulmonary disorderCOPDlungs

Rheumatology Education Goes ViRL: New Online Courses Use Interactive Platforms to Engage Fellows

Susan Bernstein  |  May 26, 2020

Interactive rheumatology education has flourished online thanks to grassroots efforts & ACR support…

Filed under:Education & Training Tagged with:COVID-19FellowsFellows-in-TrainingTrainingViRLVirtual Rheumatology Learning Collaborative (ViRL)

AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue

Kimberly Retzlaff  |  May 20, 2020

Due to the COVID-19 pandemic, the AMA House of Delegates meeting planned for June has been canceled, but the ACR’s delegation remains ready to advocate for both ongoing and new rheumatology issues, including patient protections in step therapy, prior authorization and expansion of telehealth.

Filed under:Legislation & Advocacy Tagged with:AMA House of Delegates (HOD)American Medical Association (AMA)Colin C. EdgertonCOVID-19Eileen MoynihanGary Bryanttelehealth

  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences